Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation

Addiction

Volumn 97, Issue 10, 2002, Pages 1347-1354

  Berlin, Ivan ^a   Aubin, Henri Jean ^b   Pedarriosse, Anne Marie ^c   Rames, Alexis ^c   Lancrenon, Sylvie ^d   Lagrue, Gilbert ^e  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Hôpitaux Universitaires Henri Mondor   (France)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d Sylia Stat   (France)

^e Hopital Albert Chenevier   (France)

Author keywords

Monoamine oxidase B inhibitor; Placebo controlled; Randomized study; Smoking cessation

Indexed keywords

LAZABEMIDE; PLACEBO;

ABSTINENCE; ADULT; ANXIETY NEUROSIS; ARTHRALGIA; ARTICLE; ASTHENIA; BACKACHE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; FEMALE; GASTROENTERITIS; HEADACHE; HUMAN; INSOMNIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; STOMATITIS; TOBACCO DEPENDENCE; VERTIGO; VOMITING; XEROSTOMIA;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; PICOLINIC ACIDS; SMOKING CESSATION;

EID: 0036791757     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.2002.00258.x     Document Type: Article

References (27)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, DSM-IV. Washington, DC: American Psychiatric Association.
2. Armitage, P. & Berry, G. (1987) Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications.
3. Berlin, I. & Anthenelli, R. M. (2001) Monoamine oxidases and tobacco smoking. International Journal of Neuropsychopharmacology. 4, 33-42.
4. Berlin, I., Said, S., Spreux-Varoquaux, O., Olivares, R., Launay, J.-M, & Puech, A. J. (1995a) Monoamine oxidase A and B activities in heavy smokers. Biological Psychiatry. 38, 756-761.
5. Berlin, I., Said, S., Spreux-Varoquaux, O., Launay, J.-M., Olivares, R., Millet, V., Lecrubier, Y. & Puech, A. J. (1995b) A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers, Clinical Pharmacology and Therapeutics, 58, 444-452.
6. Cesura, A. M., Borroni, E., Gottowik, J., Kuhn, C., Malherbe, P., Martin, J. & Richards, J. G. (1999) Lazabemide for the treatment of Alzheimer's disease: rationale and therapeutic perspectives. Advances in Neurology, 80, 521-528.
7. Fowler, J. S., Volkow, N. D., Logan, J., Pappas, N., King, P., MacGregor, R., Shea, C., Garza, V. & Gatley, S. J. (1998) An acute dose of nicotine does not inhibit MAOB in baboon brain in vivo. Life Sciences, 63, 19-23.
8. Fowler, J. S., Volkow, N. D., Wang, G.-J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Shea, C., Schlyer, D., Wolf, A. P., Warner. D., Zezulkova, I. & Cilento, R. (1996) Inhibition of monoamine oxidase B in the brains of smokers. Nature, 379. 733-736.
9. Fowler, J. S., Wang, G.-J., Volkow, N. D., Franceschi, D., Logan, J., Pappas, N., Colleen, S., MacGregor, R. & Garza, V. (2000) Maintenance of brain monoamine oxidase B inhibition in smokers after overnight cigarette abstinence. American Journal of Psychiatry. 157, 1864-1866.
10. Glassman, A. H. (1996) Psychoactive smoke. Nature, 379, 677-678.
11. Hall, S. M., Reus, V. L., Munoz, R. F., Sees, K. L., Humfleet, G., Hartz, D. T., Frederick, S. & Trifflemen, E. (1998) Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Archives of General Psychiatry. 55, 683-690.
12. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C. & Fagerström, K. O. (1991) The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction. 86, 1119-1127.
13. Houtsmuller, E., Thornton, J. A. & Stitzer, M. L. (2002) Effects of Selegiline (1-deprenyl) during smoking and short-term abstinence. Psychopharmacology, 163, 213-220.
14. Hughes, J. & Hatsukami, D. K. (1998) Errors in using tobacco withdrawal scale. Tobacco Control. 7, 92-93.
15. Hurt, R. D., Sachs, D. P., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. S., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., Croghan, I. T. & Sullivan, P. M. (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine. 337, 1195-1202.
16. Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., Fiore, M. C. & Baker, T. B. (1999) A controlled trial of sustained-release bupropion, a nicotine patch, both for smoking cessation. New England Journal of Medicine. 340, 685-691.
17. Khalil, A. A., Steyn, S. & Castagnoli, N. (2000) Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves. Chemical Research in Toxicology. 13, 31-35.
18. Lecrubier, Y., Sheehan, D. V., Weiller, E., Amorim, P., Bonora, I., Sheehan, K. H., Janavs, J. & Dunbar, G. C. (1997) The Mini International Neuropsychiatric Interview (MINI): a short structured diagnostic interview: reliability and validity according to the CIDI. European Psychiatry. 12, 224-232.
19. Mendez-Alvarez, E., Soto-Otero, R., Sanchez-Sellero, I. & Lamas, M. L. R. (1997) Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke. Life Sciences, 60, 1719-1727.
20. Niaura, R., Abrams, D., Shadel, W., Rohsenow, D., Monti, P. & Sirota, A. (1999) Cue exposure treatment for smoking relapse prevention: a controlled clinical trial. Addiction. 94. 685-695.
21. Oreland, L., Fowler, C J. & Schalling, D. (1981) Low platelet monoamine oxidase activity in cigarette smokers. Life Sciences. 29, 2511-2518.
22. Prochazka, A, V., Weaver, M. J., Keller, R. T., Fryer, G. E., Licari, P. A. & Lofaso, D. (1998) A randomized trial of nortritptyline for smoking cessation. Archives of Internal Medicine. 158. 2035-2039.
23. Society for Research on Nicotine and Tobacco. Subcommittee on Abstinence Measures: Hughes, J. R,. Keely, J. R., Niaura, R. S., Ossip-Klein, D. J., Richmond, R. L. & Swan, G. E. (2002) Measures of abstinence in clinical trials: issues and recommendations. Nicotine and Tobacco Research. in press.
24. Tang, J. L., Law, M. & Wald, N. (1994) How effective is nicotine replacement therapy in helping people to stop smoking? British Medical Journal. 308, 21-26.
25. Tashkin, D. P., Kanner, R., Biley, W., Buist, S., Anderson, P., Nides, M.A., Gonzales, D., Dozier, G., Patel, M.K. & Jamerson, B. D. (2001) Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet. 357, 1571-1575.
26. Whitfield, J. B., Pang, D., Bucholz, K. K., Madden, P. A. F., Heath, A. C., Statham, D. J. & Martin, N. G. (2000) Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology. Psychological Medicine. 30, 443-454.
27. Yu, P. H. & Boulton, A. A. (1987) Irreversible inhibition of monoamine oxidase by some components of cigarette smoke. Life Sciences. 41. 675-682.